Cargando…

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma

Pancreatic ductal adenocarcinoma is a stroma-rich and highly challenging cancer to treat. Over recent years, it has become increasingly evident that the complex network of soluble cytokines, growth factors, proteases, and components of the extracellular matrix collaboratively interact within the tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neesse, Albrecht, Krug, Sebastian, Gress, Thomas M, Tuveson, David A, Michl, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872146/ https://www.ncbi.nlm.nih.gov/pubmed/24379681 http://dx.doi.org/10.2147/OTT.S38111

Ejemplares similares

Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma Gangrenosum
por: Neesse, Albrecht, et al.
Publicado: (2007)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

Screening Technologies for Target Identification in Pancreatic Cancer
por: Michl, Patrick, et al.
Publicado: (2010)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2019)

Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature
por: Krug, Sebastian, et al.
Publicado: (2016)

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2020)

Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome
por: Krug, Sebastian, et al.
Publicado: (2019)

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
por: Rinke, Anja, et al.
Publicado: (2012)

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
por: Schmitz, Rosa Lynn, et al.
Publicado: (2021)

Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma
por: Ahn, Daniel H., et al.
Publicado: (2018)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
por: McKenna, Mary K, et al.
Publicado: (2023)

Targeting the Stroma in the Management of Pancreatic Cancer
por: Edwards, Penelope, et al.
Publicado: (2021)

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification
por: Krug, Sebastian, et al.
Publicado: (2015)

Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020)

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Courtin, Aurélie, et al.
Publicado: (2013)

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
por: Polani, Faran, et al.
Publicado: (2021)

Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm
por: Boch, Michael, et al.
Publicado: (2014)

Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
por: Lohse, Ines, et al.
Publicado: (2014)

Therapeutic Targeting of Hyaluronan in the Tumor Stroma
por: Kultti, Anne, et al.
Publicado: (2012)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)

Transient targeting of the pancreatic cancer stroma as a ‘fine-tuned’ anti-tumor and anti-metastatic therapy
por: Vennin, Claire, et al.
Publicado: (2017)

Revisiting stroma in pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2015)

T cells in pancreatic cancer stroma
por: Goulart, Michelle R, et al.
Publicado: (2021)

Pancreatic cancer, stroma, and exosomes
por: Closa, Daniel
Publicado: (2022)

Targeting Tumor Stroma: Exploiting Apoptotic Priming
por: Mertens, Joachim C., et al.
Publicado: (2012)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020)

Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer
por: Hasselluhn, Marie C., et al.
Publicado: (2019)

Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (PREVADER): Clinical Feasibility Trial
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2021)

Key aspects for conception and construction of co-culture models of tumor-stroma interactions
por: Mason, James, et al.
Publicado: (2023)

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease
por: Krug, Sebastian, et al.
Publicado: (2022)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis
por: Egidi, Maren Juliane, et al.
Publicado: (2023)

B cells in pancreatic cancer stroma
por: Delvecchio, Francesca Romana, et al.
Publicado: (2022)

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
por: Nicolle, Rémy, et al.
Publicado: (2017)

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
por: Modica, Chiara, et al.
Publicado: (2018)

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
por: Jiang, Bolun, et al.
Publicado: (2020)

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
por: Mueller, Daniela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u7scjlloa2d96g9bd1aqut8n5h